Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 12 Aug 2026 for Replimune Group, Inc., €86k. Read the official filing
Filing timeline
BuySaleAndrew Schwendenman
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Andrew Schwendenman: trading record in brief
All filings by Andrew Schwendenman on record concern Replimune Group, Inc. Between 1 April 2024 and 10 August 2026, the trades on record add up to 7 filings.
No open-market purchase appears, only 3 sales worth €123k. Outside the open market, there are 4 share grants. So far in 2026, the count stands at no purchases and 1 sale.
Most recently, on 12 August 2026, the filings show an open-market sale worth €86k in Replimune Group, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andrew Schwendenman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
7,632 shares@ US$12.970.0082% mcap69.8% of flowCommon StockSEC:0001104659-26-095003:0
36,667 shares0Common StockSEC:0001104659-26-040572:0
10,000 shares0Common StockSEC:0001104659-25-123279:0
3,287 shares@ US$8.0519.1% of flowCommon StockSEC:0001104659-25-052144:0
33,333 shares0Common StockSEC:0001104659-25-031823:0
2,298 shares@ US$6.4711.1% of flowCommon StockSEC:0001104659-24-063563:0
17,775 shares0Common StockSEC:0001104659-24-043246:0
7 of 7 declarations
